Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Recruiting 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 127Tumor-Agnostic 111Thoracic 86Breast 82Genitourinary 69Gynecologic 49Dermatologic 45Head & Neck 43Sarcoma 31CNS 27Other hematologic neoplasm 12Lymphoid 11Endocrine 8NET 4Myeloid 4Other solid neoplasm 3Plasma cell 2

Conditions

Neuroendocrine Tumors 69Gastro-enteropancreatic neuroendocrine tumor 8Pheochromocytoma 7Carcinoma, Neuroendocrine 7Carcinoid Tumor 7Adenoma, Islet Cell 7Paraganglioma 6Neoplasms 5Melanoma 5Breast Neoplasms 5Thyroid Neoplasms 4Sarcoma 4Pancreatic Neoplasms 4Neuroblastoma 4Neoplasm Metastasis 4Carcinoma 4Serotonin Syndrome 3Prostatic Neoplasms 3Ovarian Neoplasms 3Neuroectodermal Tumors, Primitive 3Mesothelioma 3Meningioma 3Liver Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Merkel Cell 3Carcinoma, Hepatocellular 3Anus Neoplasms 3

Interventions

fludarabine phosphate 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Fluorodeoxyglucose F18 1Everolimus 1Cyclophosphamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasm Metastasis × NET × 90 days × Clear all
NCT07377487 2026-05-22

INDIGO

Boston Scientific Corporation

Phase NA Recruiting
51 enrolled
EndocrineGastrointestinalNET

Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT07129252 2026-05-11

BRAVESST2

Crinetics Pharmaceuticals Inc.

Phase 1/2 Recruiting
150 enrolled
EndocrineNET

Neoplasm Metastasis, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06943755 2026-04-17

STELLAR-311

Exelixis

Phase 2/3 Recruiting
440 enrolled
EndocrineNET

Adenoma, Islet Cell, Neoplasm Metastasis, Neuroendocrine Tumors

NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡